COMMUNIQUÉS West-GlobeNewswire

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
12/11/2024
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed [...]
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
12/11/2024
Appointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus erythematosus (SLE) Expanded Management Team with the Appointment of [...]
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
12/11/2024
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
12/11/2024
Submission of New Drug Application for Paltusotine for the Treatment of Acromegaly Completed Upsized Public Offering of $575M of Common Stock Debut of First Drug Candidate from a Novel Nonpeptide Drug Conjugate Platform [...]
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
12/11/2024
Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK ® in autoimmune diseases Initial data for AlloNK ® in autoimmune indications expected [...]
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
12/11/2024
CANTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
OrthoPediatrics Corp. to Participate in Upcoming Conferences
12/11/2024
WARSAW, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
12/11/2024
Advanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this quarter Commenced the manufacture of registration batches of Mydcombi in its [...]
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
12/11/2024
Presented preclinical data further supporting the potential best-in-class profile of ORIC-114 to treat EGFR exon 20 insertions and other atypical mutations at the EORTC-NCI-AACR Conference Announced clinical [...]
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
12/11/2024
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus ™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue increase for Q3 2024, [...]
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
12/11/2024
Advanced to the highest dose level in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancers Presented updated preclinical activity of BDC-4182 and key learnings from Phase 1 dose- [...]
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
12/11/2024
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
QIAGEN collaborates with McGill University to advance microbiome research
12/11/2024
QIAGEN and McGill University to collaborate on microbiome research projects to generate evidence-based knowledge for medicine and public health // McGill will serve as a beta-testing site for new QIAGEN microbiome [...]
Iridex Reports Third Quarter 2024 Financial Results
12/11/2024
MOUNTAIN VIEW, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
12/11/2024
Interim data from initial dose escalation cohorts of Phase 1 CARDINAL trial evaluating TERN-701 (allosteric BCR-ABL tyrosine kinase inhibitor) in chronic myeloid leukemia (CML) expected in early December 2024 Plans to [...]
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
12/11/2024
Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple Clinical Complete Responses [...]
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates
12/11/2024
- Submitted regulatory filing for first-in-human clinical study of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) - Formed Clinical Advisory Board (CAB) of leading lung and liver experts and [...]
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
12/11/2024
MELVILLE, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
12/11/2024
- Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Secondary Outcomes - - Positive Topline Results Support Advancing CLS-AX to Phase 3 Targeting a Differentiated Flexible Dosing [...]

Pages